Industry News - Tag: TGA

You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.

Australia gives go-ahead for OTC CBD products
Premium

16 December 2020

Australia’s Therapeutic Goods Administration (TGA) has now given the final go-ahead for certain low-dose cannabidiol (CBD) medicines to be sold without a prescription. However, the TGA has made a number of changes to its interim decision released in September 2020.

Read the full story

Regulatory in brief | Europe, global collaboration, US

28 April 2020

In response to the COVID-19 pandemic, the European Council has adopted the European Commission’s proposal to postpone by one year the date of application of the new Medical Devices Regulation, regulatory agencies around the world have stepped up global collaboration, and the US has taken action on h...

Read the full story

Regulatory in brief | FDA, TGA, MHRA

24 October 2019

The US Food and Drug Administration (FDA) has updated its approach to homeopathic products, Australia’s Therapeutic Goods Administration (TGA) is consulting on a proposal affecting supports supplements, and the UK's Medicines and Healthcare products Regulatory Agency (MHRA) has announced a promotion...

Read the full story